View Older Stories View More Recent Stories

Aug 10, 2023 04:05PM ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
Aug 4, 2023 04:30PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 26, 2023 08:30AM ORIC Pharmaceuticals (ORIC) Announces $85 Million Private Placement Financing of Common Stock, Warrants
Jun 26, 2023 08:30AM ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
Jun 2, 2023 04:15PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2023 04:10PM ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
May 8, 2023 04:05PM ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
May 5, 2023 04:15PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr 25, 2023 04:30PM ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference
Apr 18, 2023 04:16PM ORIC Pharmaceuticals (ORIC) Presents Promising Preclinical Data on Two Programs
Apr 18, 2023 04:15PM ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Apr 18, 2023 04:15PM ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Mar 16, 2023 04:05PM ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Mar 16, 2023 04:05PM ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Mar 14, 2023 04:30PM ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Mar 14, 2023 04:30PM ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Mar 6, 2023 04:15PM ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Feb 3, 2023 04:30PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Feb 1, 2023 04:30PM ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Jan 9, 2023 08:19AM ORIC Pharmaceuticals (ORIC) Provides Corporate Update and Highlights Key Upcoming Milestones
Jan 9, 2023 08:00AM ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Jan 9, 2023 08:00AM ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Jan 3, 2023 04:30PM ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Dec 13, 2022 08:00AM ORIC Pharmaceuticals (ORIC) Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology
Dec 13, 2022 08:00AM ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting
Dec 13, 2022 08:00AM ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting
Nov 8, 2022 04:10PM ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Nov 7, 2022 04:05PM ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
Nov 7, 2022 04:05PM ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
Nov 3, 2022 09:00AM ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
Nov 3, 2022 09:00AM ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
Oct 7, 2022 04:30PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Sep 1, 2022 04:15PM ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 11, 2022 04:05PM ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
Aug 11, 2022 04:05PM ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
Jun 2, 2022 04:10PM ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 17, 2022 04:10PM ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
May 9, 2022 04:05PM ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
May 9, 2022 04:05PM ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
Apr 12, 2022 04:07PM ORIC Pharmaceuticals Inc. (ORIC) Presents Data from Three Promising Preclinical Programs
Apr 12, 2022 04:05PM ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Apr 12, 2022 04:05PM ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Mar 21, 2022 04:00PM ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
Mar 21, 2022 04:00PM ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
Mar 17, 2022 04:30PM ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call
Mar 17, 2022 04:30PM ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call
Mar 8, 2022 04:30PM ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Mar 8, 2022 04:30PM ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Feb 2, 2022 04:30PM ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference
Jan 25, 2022 08:30AM ORIC Pharmaceuticals Inc. (ORIC) Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications
View More Recent Stories View Older Stories